ZYVERSA THERAPEUTICS, INC. Intangible Assets, Net (Excluding Goodwill)
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Intangible Assets, Net (Excluding Goodwill) of $30.81 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2023-11-14
- 2023-09-30: Intangible Assets, Net (Excluding Goodwill) $30.81M.
- 2022-12-31: Intangible Assets, Net (Excluding Goodwill) $100.09M.
| Period end | Intangible Assets, Net (Excluding Goodwill) |
|---|---|
| 2023-09-30 | $30.81M 10-Q · filed 2023-11-14 |
| 2022-12-31 | $100.09M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |